Ludmila Bess, MD
Gynecology · Los Angeles, CANPI 1780633537
Payments from drug & device makers
Across 67 payments — averaging $22.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$400
- Avion Pharmaceuticals$162
- Davol Inc.$90
- Bayer$74
- Hologic Sales And Service, LLC$73
- Astellas Pharma US Inc$70
- plus $635 from 18 others
What the payments were for
- Food & beverage$1,48799%
- Education$171%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 20 | $400 |
| Avion Pharmaceuticals | 9 | $162 |
| Davol Inc. | 1 | $90 |
| Bayer | 3 | $74 |
| Hologic Sales And Service, LLC | 3 | $73 |
| Astellas Pharma US Inc | 3 | $70 |
| Exeltis, USA Inc. | 3 | $59 |
| Merck | 2 | $57 |
| Pfizer | 2 | $50 |
| Sage Therapeutics, LLC | 2 | $47 |
| Coopersurgical, Inc. | 2 | $45 |
| Therapeuticsmd, Inc. | 3 | $43 |
| Covidien LP | 1 | $41 |
| Baxter Healthcare | 1 | $36 |
| Dysis Medical, Inc. | 2 | $35 |
| Lupin Inc. | 2 | $34 |
| Mayne Pharma Commercial LLC | 1 | $32 |
| AstraZeneca | 1 | $29 |
| Sumitomo Pharma America, Inc. | 1 | $27 |
| Millicent US Inc | 1 | $25 |
| BD | 1 | $21 |
| Urovant Sciences Inc | 1 | $21 |
| Sanofi | 1 | $18 |
| AMAG Pharmaceuticals, Inc. | 1 | $17 |
How this compares
$1,504 in reported general payments places this provider in the 60th percentile of 247 gynecology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 117 | $7,219 |
| ValacyclovirValacyclovir Hcl | 36 | $901 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 50 | $893 |
| Raloxifene Hcl | 14 | $308 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 24 | $266 |
| Medroxyprogesterone Acetate | 13 | $248 |
| ProgesteroneProgesterone, Micronized | 31 | $230 |
| Nystatin | 32 | $157 |
| Valsartan | 15 | $108 |
| Fluconazole | 16 | $103 |
| Triamcinolone Acetonide | 26 | $38 |
| Gabapentin | 11 | $33 |
| Amlodipine Besylate | 14 | $17 |
| Diazepam | 12 | $12 |
| Hydrochlorothiazide | 11 | $3 |
Paid to pharmacies, not to this prescriber.
Other gynecology in Los Angeles
- Kelly WrightLos Angeles$119K
- Brian NguyenLos Angeles$10K
- Kevin PhungLos Angeles$7K
- Claire TemplemanLos Angeles$6K
- Diamond GoodwinLos Angeles$4K
- Bruce LeeMonterey$2.8M
- Robert SemoSan Diego$2.8M
- Gioi Smith NguyenSan Diego$1.4M
- Barbara Levyla Jolla$780K
- Thomas EasterRancho Cucamonga$360K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.